stockrowInMed Pharmaceuticals Inc. (INM) vs Sonoma Pharmaceuticals, Inc. (SNOA)
- InMed Pharmaceuticals Inc. INM 14.74 +11.58%
- Sonoma Pharmaceuticals, Inc. SNOA 1.09 +1.87%
InMed Pharmaceuticals Inc. and Sonoma Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. InMed Pharmaceuticals Inc. is the larger, with a market value of $7.3M against $5.1M — 1.4× the size. Sonoma Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 47.0% against −6.73%. InMed Pharmaceuticals Inc. has the higher net margin (0.00% vs −10.3%) and the higher return on invested capital (0.00% vs −70.0%). Across the 15 metrics below, InMed Pharmaceuticals Inc. leads on 8 and Sonoma Pharmaceuticals, Inc. on 7.
Valuation
Profitability
| Metric | INM | SNOA | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 33.62% | 38.91% | 53.51% |
| Operating margin | 0.00% | (6.41%) | 0.00% |
| Net margin | 0.00% | (10.33%) | (2.45%) |
| Free cash flow margin | 0.00% | (12.11%) | 0.00% |
| Return on equity | (261.69%) | (42.52%) | (0.80%) |
| Return on assets | (185.40%) | (13.85%) | (1.67%) |
| Return on invested capital | 0.00% | (69.96%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack